Volver a News
NOTICIA
Chambers & Partners Europe 2024 results
14 de March, 2024
The results of the latest edition of the prestigious legal directory, Chambers & Partners, in its Europe 2024 edition are now public. These results are a reflection of the work of many of the Firm’s professionals and the assessments of our clients and competitors.
Improvements over the previous edition
Congratulations to all!
Improvements over the previous edition
Areas:
- Restructuring moves up to Band 1
- Competition & EU law moves up to Band 3
Individuals:
- Rodrigo López moves up to Band 1 in Insolvency
- Inés Vázquez moves up to Band 3 in Dispute Resolution
- Sofía Martínez-Almeida moves up to Band 3 in IP: Patents and Trademarks
- Guillermo Guerra enters as Band 4 in Equity Capital Markets
- Álvaro Mateo enters as Band 6 in Corporate / M&A
- Rodrigo López enters as Band 6 in Dispute Resolution
- Pablo Fernández Cortijo enters in Corporate / M&A as Up and Coming
Montserrat Jané enters in Dispute Resolution : Barcelona as Associate to watch
Congratulations to all!
Abogado mencionado
Rodrigo López – Partner
Inés Vázquez – Partner
Ver todos los abogados
Ver menos abogados
More information about
Gómez-Acebo & Pombo
01 Oct, 2026 
PUBLICACIÓN
21 Sep, 2026
Pharma & Healthcare No. 50
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
21 Sep, 2026 
PUBLICACIÓN
17 Jul, 2026
Claim assignment and assignment of right to rescind underlying contract
There is no single answer to the question of whether or not the assignee of a claim has the power to rescind the underlying contract when the assigned debtor defaults. As a general rule, such rescission will not be possible for the assignee.
17 Jul, 2026
PUBLICACIÓN
16 Jul, 2026
New EU regulation on the screening of foreign investments
Regulation (EU) 2026/1386 establishes a harmonised and mandatory framework for the screening of foreign investments in the Union and replaces the previous Regulation (EU) 2019/452. Among its most notable new features are the obligation for all Member States to have a national screening mechanism with harmonised minimum requirements; the inclusion within its scope of investments made by European subsidiaries controlled by third-country investors; the implementation of a two-stage national procedure; and the strengthening of the European cooperation mechanism through a risk-screening system and a more stringent “comply or explain” principle.
Finally, the paper analyses the regulation’s impact on Spain, whose current review mechanism must be adapted in areas such as procedural structure, the review of completed transactions, sectoral expansion, and the penalty regime by 17 January 2028.
16 Jul, 2026
PUBLICACIÓN
23 Jun, 2026
Pharma & Healthcare No. 49
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
23 Jun, 2026
PUBLICACIÓN
09 Jun, 2026
Partial limitation defences that may be raised in relation to the limitation period within a cartel (Supreme Court Judgment no. 681/2026 of 6 May)
A flawed judgment on a problem that has remained unresolved to date in the truck cartel. The issue is not whether the liability-in-solidum regime applies, but whether co-liable parties can raise personal defences.
09 Jun, 2026
PUBLICACIÓN
04 Jun, 2026
Unanimous shareholders' agreements and dividends in specie
The Supreme Court and the Madrid Provincial Court, following established legal doctrine, have reiterated that a party to a unanimous shareholders’ agreement acts in bad faith if he or she challenges a company resolution passed in compliance with said shareholders’ agreement. In this case, the shareholders’ agreement provided for the possibility of paying dividends in kind, and the contested resolution — which was passed by a majority at the shareholders’ meeting — transferred certain real estate properties to one of the shareholders (with his consent) in payment of the dividend due to him.
04 Jun, 2026
PUBLICACIÓN
27 May, 2026
An action for declaration of invalidity of an already-terminated franchise agreement is admissible
An action for declaration of invalidity of an agreement can almost always be brought, even if the agreement has been performed and terminated.
27 May, 2026
PUBLICACIÓN
30 Apr, 2026
Pharma & Healthcare No. 48
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
30 Apr, 2026
PUBLICACIÓN
27 Apr, 2026
Separate restructuring strategies among joint and several co-debtors
The basis for this paper is a slightly modified real-life case, broadened to include all possible forms of plurality of debtors.
27 Apr, 2026